Merck Sharp & Dohme, LLC v. Mylan Pharmaceuticals Inc.
Plaintiff / Appellee: MERCK SHARP & DOHME, LLC
Defendant / Appellant: MYLAN PHARMACEUTICALS INC.
Case Number: 23-1013
Filed: October 5, 2022
Court: U.S. Court of Appeals, Federal Circuit
Nature of Suit: Patent Infringement (Fed. Qst.)

Opinions

We have the following opinions for this case:

Date Filed Description
May 11, 2023 MERCK SHARP & DOHME, LLC v. MYLAN PHARMACEUTICALS INC.

Docket Report

This docket was last retrieved on November 23, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
November 23, 2022 Filing 11 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 10 ] filed by Appellant Mylan Pharmaceuticals Inc. The opening brief is due 01/19/2023. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [886349] [EKD] [Entered: 11/23/2022 10:56 AM]
November 21, 2022 Filing 10 MOTION of Appellant Mylan Pharmaceuticals Inc. to extend the time to 01/19/2023 to file brief. Service: 11/21/2022 by email. [885686] [23-1013] [Eric Werlinger] [Entered: 11/21/2022 07:00 PM]
October 21, 2022 Filing 9 This entry was made in error and has been removed from the docket. NOTICE OF NON-COMPLIANCE: The submission of Appellee Merck Sharp & Dohme, LLC, Entry of Appearance [ # 2 ], is not in compliance with the rules of this court (see attached). Service as of this date by the Clerk of Court. [879402] [MMA] [Entered: 10/21/2022 11:55 AM]
October 19, 2022 Filing 8 Certificate of Interest for Appellant Mylan Pharmaceuticals Inc.. Service: 10/19/2022 by email. [879094] [23-1013] [Deepro Mukerjee] [Entered: 10/19/2022 06:45 PM]
October 19, 2022 Filing 7 Docketing Statement for the Appellant Mylan Pharmaceuticals Inc.. Service: 10/19/2022 by email. [879093] [23-1013] [Deepro Mukerjee] [Entered: 10/19/2022 06:44 PM]
October 19, 2022 Filing 6 Entry of appearance for Deepro Mukerjee;Lance Soderstrom;Jitendra Malik;Robert T. Smith;Eric T. Werlinger as counsel for Appellant Mylan Pharmaceuticals Inc.. Service: 10/19/2022 by email. [879092] [23-1013] [Deepro Mukerjee] [Entered: 10/19/2022 06:42 PM]
October 19, 2022 Filing 4 Certificate of Interest for Appellee Merck Sharp & Dohme, LLC. Service: 10/19/2022 by email. [878851] [23-1013] [Jeffrey Lamken] [Entered: 10/19/2022 10:46 AM]
October 19, 2022 Filing 3 Docketing Statement for the Appellee Merck Sharp & Dohme, LLC. Service: 10/19/2022 by email. [878850] [23-1013] [Jeffrey Lamken] [Entered: 10/19/2022 10:45 AM]
October 19, 2022 Filing 2 Entry of appearance for Jeffrey A. Lamken; Michael G. Pattillo, Jr.; Caleb Hayes-Deats; Mark W. Kelley; Bruce R. Genderson; Stanley E. Fisher; David M. Krinsky; Charles L. McCloud; Shaun P. Mahaffy; Anthony Sheh as counsel for Appellee Merck Sharp & Dohme, LLC. Service: 10/19/2022 by email. [878848] [23-1013] [Jeffrey Lamken] [Entered: 10/19/2022 10:43 AM]
October 5, 2022 Filing 1 Appeal docketed. Received: 10/03/2022. [876181] Entry of Appearance due 10/19/2022. Certificate of Interest is due on 10/19/2022. Docketing Statement due 10/19/2022. Appellant's brief is due 12/05/2022. [MMA] [Entered: 10/05/2022 03:46 PM]

Access additional case information on PACER

Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Search for this case: Merck Sharp & Dohme, LLC v. Mylan Pharmaceuticals Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff / appellee: MERCK SHARP & DOHME, LLC
Represented By: Anthony Sheh
Represented By: Jeffrey A. Lamken
Represented By: Stanley E. Fisher
Represented By: Bruce Genderson
Represented By: Caleb Hayes-Deats
Represented By: Mark W. Kelley
Represented By: David M. Krinsky
Represented By: Shaun Patrick Mahaffy
Represented By: Charles McCloud
Represented By: Michael Gregory Pattillo Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: MYLAN PHARMACEUTICALS INC.
Represented By: Gordon H. Copland Esq.
Represented By: Deepro Mukerjee
Represented By: Jitendra Malik Esq.
Represented By: Robert Thomas Smith Esq.
Represented By: Lance Soderstrom
Represented By: Eric Thomas Werlinger
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?